Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics
Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930.
Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930. Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930. Moneycontrol Latest News Read More
Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930.







